News Stories by Tag

4-Aminoquinolines inhibit the function of the bacterial T-box riboswitch RNA. Illustration by Jennifer Hines

Hiding in plain sight: Hines group uncovers new class of medicinal compounds that target RNA

February 12, 2023 4 min

Chemistry students in Jennifer Hines' lab uncovered a new class of compounds that can target RNA and disrupt its function, a discovery that could be used in the development of RNA-targeted medicines.

Ohio University professors (left to right) Douglas Goetz, Stephen Bergmeier and Kelly McCall, who discovered a compound that can possibly help protect against a plethora of physiological and pathophysiological diseases.

Alumna Kelly McCall veered into a research career fighting autoimmune and inflammatory diseases

December 21, 2022 4 min

Kelly McCall thought she was headed to dentistry school. But as graduation loomed, she changed her major to biological sciences and found herself on a very different health-care related path.

Jon Snyder on his graduation day in June 1987 with his parents, Glenn and Anne Snyder.

Alumnus Jon Snyder helped make patients' lives better through medical devices, therapies

December 21, 2022 6 min

When Jon Snyder was a communications major at OHIO, the closest he came to the field of health care was a marketing and communications internship with the Heritage College of Osteopathic Medicine.

Stories tagged with: Health Impact

Hiding in plain sight: Hines group uncovers new class of medicinal compounds that target RNA

Alumna Kelly McCall veered into a research career fighting autoimmune and inflammatory diseases

Alumnus Jon Snyder helped make patients' lives better through medical devices, therapies